Reported Jan 29, 2014 · Terminated
REPAGLINIDE, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008481.
Aidapak Services, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aidapak Services, LLC · 14301 Se 1st St · Vancouver, WA · 98684-3501
Is this the product you have?
- REPAGLINIDE, Tablet, 2 mg, Rx only
- Distributed byAidaPak Service, LLC, NDC 00169008481
- Lot codes and dates
- REPAGLINIDE, Tablet, 2
- mg has the following codesPedigree: AD46419_4
- EXP5/16/2014
- PedigreeAD70639_13
- EXP5/29/2014
- PedigreeW003925
- EXP7/1/2014
- Amount recalled
- 500 Tablets
This recall covers 265 products
The agency filed one notice per product. You are reading one of them; the other 264 are below.
252 more are in the archive.
Where it was sold
Why it was recalled
Labeling: Label Mixup: REPAGLINIDE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs: COLCHICINE, Tablet, 0.6 mg, NDC 64764011907, Pedigree: AD46419_1, EXP: 5/16/2014; PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121207, Pedigree: AD70639_7, EXP: 5/29/2014; DARUNAVIR, Tablet, 800 mg, NDC 59676056630, Pedigree: W003929, EXP: 7/1/2014.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aidapak Services, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.